Trial intelligence / Profile preview

Zhenyuan Capsule for cardiopulmonary function in stable coronary heart disease

ChiCTR2000032818Phase 4Not yet recruiting

Sponsor
Xiyuan Hospital
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Zhenyuan Capsule in coronary arteriosclerosis (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Peak oxygen uptake. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

Zhenyuan Capsule
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ChiCTR2000032818.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032818.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call